According to recent data, the total economic output from legal cannabis will grow 150% from $16 billion in 2017 to $40 billion by 2021.
Hemp CBD sales hit $170 million in 2016 and at a 55% compound annual growth rate over the years to come, the market will easily cross the billion-dollar mark.
Dr. Jonathan Page, Co-Founder, President and CEO of Anandia Labs, and an internationally-recognized pioneer in cannabis plant biochemistry and genetics, was also voted Most Progressive Researcher for 2017.
The Emerald Test Badge results provide a measure of assurance and reliability to the industry as a whole, and particularly to those who depend on testing lab's results for safety, health, and product performance.
Analyses of 11 cannabinoids and 19 terpenoids in 2,237 individual cannabis flower samples identified three distinct clusters that were distinguishable by terpenoid profiles alone.
Attaching a light-sensitive “antenna” to the THC molecule makes it possible to use light of a specific wavelength to precisely manipulate the CB1 receptor.
GB Sciences is seeking to place cannabis-based medical formulations on a level playing field with traditional medical formulations when it comes to patient studies and clinical trials.
Theie goal is to be able to produce a custom flower strain with custom cannabinoids and terpenes that can be tailored for specific end use applications, such as sleep or pain relief.
Effective January 1, 2018, C3 Labs LLC was also granted its temporary testing license from the State of California, and will operate under the brand EVIO Labs Berkeley.